IDEAYA is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines for genetically defined patient populations and immuno-oncology therapies targeting immuno-metabolism and innate immunity. IDEAYA, headquartered in South San Francisco, California, has assembled leading scientists and advisors with extensive knowledge and expertise in cancer biology, immunology, and small molecule drug discovery.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/15/18 | $94,000,000 | Series B |
5AM Ventures 6 Dimensions Capital  Boxer Capital BVF Partners Canaan Partners Celgene Corporation Driehaus Capital Management Nextech Invest Perceptive Advisors Roche Venture Fund WuXi Healthcare Ventures | undisclosed |
